Susquehanna International Group
CTSO icon

Susquehanna International Group’s Cytosorbents Corp CTSO Stock Holding History

Susquehanna International Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-755
Closed -$50.9K – 12209
2023
Q1 		$50.9K Buy
+755
New +$45.3K ﹤0.01% 11696
2022
Q3 		– Sell
-1,300
Closed -$57K – 13290
2022
Q2 		$57K Buy
1,300
+195
+18% +$8.95K ﹤0.01% 11893
2022
Q1 		$70K Buy
+1,105
New +$79.2K ﹤0.01% 12129
2021
Q4 		– Sell
-1,525
Closed -$248K – 13196
2021
Q3 		$248K Buy
1,525
+260
+21% +$42.2K ﹤0.01% 11025
2021
Q2 		$191K Sell
1,265
-1,335
-51% -$225K ﹤0.01% 11641
2021
Q1 		$451K Buy
2,600
+935
+56% +$178K ﹤0.01% 9713
2020
Q4 		$265K Buy
1,665
+530
+47% +$88.7K ﹤0.01% 9529
2020
Q3 		$181K Sell
1,135
-4,180
-79% -$754K ﹤0.01% 9537
2020
Q2 		$1.05M Buy
5,315
+3,515
+195% +$646K ﹤0.01% 5807
2020
Q1 		$278K Buy
+1,800
New +$182K ﹤0.01% 8124
2018
Q4 		– Sell
-1,365
Closed -$352K – 9062
2018
Q3 		$352K Sell
1,365
-890
-39% -$223K ﹤0.01% 7156
2018
Q2 		$514K Sell
2,255
-1,775
-44% -$336K ﹤0.01% 6724
2018
Q1 		$568K Buy
4,030
+1,775
+79% +$268K ﹤0.01% 6369
2017
Q4 		$293K Buy
+2,255
New +$287K ﹤0.01% 7632
2017
Q3 		– Sell
-765
Closed -$66K – 8912
2017
Q2 		$66K Sell
765
-385
-33% -$33.8K ﹤0.01% 8830
2017
Q1 		$104K Buy
1,150
+340
+42% +$38K ﹤0.01% 8367
2016
Q4 		$88K Sell
810
-1,790
-69% -$196K ﹤0.01% 9132
2016
Q3 		$333K Buy
2,600
+1,095
+73% +$114K ﹤0.01% 6760
2016
Q2 		$137K Sell
1,505
-570
-27% -$49.6K ﹤0.01% 7866
2016
Q1 		$163K Sell
2,075
-3,945
-66% -$342K ﹤0.01% 8147
2015
Q4 		$671K Buy
6,020
+2,415
+67% +$329K ﹤0.01% 6225
2015
Q3 		$455K Sell
3,605
-600
-14% -$80K ﹤0.01% 7302
2015
Q2 		$520K Buy
+4,205
New +$572K ﹤0.01% 7566

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group's CTSO Position: Q2 2026 in Review

Susquehanna International Group sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 1,497 shares — an estimated $17K sold.

Susquehanna International Group first reported a position in CTSO in Q1 2015 and held it in 36 quarters. The position peaked at $1.11M in Q3 2017. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Susquehanna International Group reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,497 Cytosorbents Corp shares in Q2 2026, an estimated $17K.
  • Susquehanna International Group first reported a position in Cytosorbents Corp in Q1 2015 and held it in 36 quarters.
  • Susquehanna International Group's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.